Skip to content
FDAMedical devices

BD Issues Nationwide Recall for Specific Lots of BD® Intraosseous Vascular Access System Needle Sets Due to Reports of Difficulty Removing the Obturator

FDA recall n-bd-issues-nationwide-recall-specific-lots-bdr-intraosseous-vascular-access-syste ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Due to Reports of Difficulty Removing the Obturator
Text from FDA, unedited.

The recalled product

FRANKLIN LAKES, N.J. (July 31, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of BD® Intraosseous Vascular Access System Needle Sets to the user level. These products are being recalled following reports that some users experienced difficulty removing the obturato
Text from FDA, unedited.

Company announcement, as FDA publishes it

FRANKLIN LAKES, N.J. (July 31, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of BD® Intraosseous Vascular Access System Needle Sets to the user level. These products are being recalled following reports that some users experienced difficulty removing the obturator (stylet) after placement of the needle set. Based on complaint reports, bench testing completed by BD and clinical observations, this may occur if the drill is not pulled straight back during insertion or if the obturator is incorrectly rotated during removal.

The affected lots were manufactured with out of tolerance dimensions and distributed between September 30, 2024, and June 12, 2026. This recall does not affect the BD® Intraosseous Powered Driver.

Risk Statement : If the obturator cannot be removed, the clinician may need to obtain a new IO needle or alternative vascular access device, such as a Peripheral IV catheter, potentially delaying therapy initiation. Patients at greatest risk are critically ill individuals requiring urgent vascular access, including out-of-hospital cardiac arrest and severe trauma patients. Delays to therapy initiation may result in serious injury or death. Through June 2026, BD has received 75 complaints and reported 45serious injury reports. BD has also reported 4 deaths in which the inability to remove the stylet occurred during resuscitation efforts for out-of-hospital cardiac arrests.

*Additional information can be found in the customer letter, available here .

BD is notifying its customers and distributors who may have received these lots of product directly. Customers and distributors should immediately discontinue use of these lots and destroy all affected needle sets in accordance with their facility’s process.

BD will issue replacement for destroyed product of the affected lot numbers to customers that purchased the affected product directly from BD, following receipt of the completed Customer Response Form.

BD has identified the root cause of this issue and implemented corrective and preventative action, including product and labeling improvements, to enhance device robustness and reduce the likelihood of recurrence. Product distributed outside of the affected production window is not impacted.

Customer inquiries related to this recall, as well as adverse reaction/events experienced with the product, should be addressed to BD’s North American Regional Complaint Center: 1-844-823-5433 (Toll Free) Monday – Friday between the hours of 8 a.m. and 5 p.m. CT or by emailing: productcomplaints@bd.com .

FDA MedWatch Reporting

Adverse reactions/events experienced with the use of any of these products should also be reported to the FDA's MedWatch Adverse Event Reporting program either online, phone or by regular mail.

Complete and submit the report Online : www.fda.gov/medwatch/report.htm

Call 1-800-FDA-1088 (1-800-332-1088)

Regular Mail : MedWatch, HF-2, FDA, 5600 Fisher’s Lane, Rockville, MD 20852-9787

The U.S. Food and Drug Administration (FDA) has been notified of this recall.

# # #

About BD BD is one of the world’s largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X @BDandCo or Instagram @becton_dickinson .

Contacts:

Media Matt Marcus VP, Public Relations Matt.Marcus@bd.com

Investors Shawn Bevec SVP, Investor Relations Investor_Relations@bd.com

Text from FDA (the company’s words), unedited.
  • Needle Kit for Powered Driver 15mm x 15Ga 6 kits per case

    Lot or code
    Catalog ; No.: D015151NK; Lot No.: See ; Appendix 1; in customer; letter*; UDI-DI: 00801741163586; Expiration ; Date: See ; Appendix 1; in customer; letter*
  • Needle Kit for Powered Driver 25mm x 15Ga

    Lot or code
    Catalog ; No.: D015251NK; Lot No.: 00801741163678
  • Needle Kit for Powered Driver 35mm x 15Ga

    Lot or code
    Catalog ; No.: D015351NK; Lot No.: 00801741163593
  • Needle Kit for Powered Driver 45mm x 15Ga

    Lot or code
    Catalog ; No.: D015451NK; Lot No.: 00801741163609
  • Needle Kit for Powered Driver 55mm x 15Ga

    Lot or code
    Catalog ; No.: D015551NK; Lot No.: 00801741163616

Source

Issued by
U.S. Food and Drug Administration
Firm
(Becton, Dickinson and Company)

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: (Becton, Dickinson and Company), Month: July 2026, Week 2026-W31. Browse more medical devices recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Due to Reports of Difficulty Removing the Obturator”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published this company announcement on July 30, 2026.

Other notices of (Becton, Dickinson and Company)